GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 521, 294-307
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF-2019R1A2C2007207, NRF-2019R1A6A1A10073887, NRF-2020M3E5E2037170)
This publication has 62 references indexed in Scilit:
- Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasivenessProceedings of the National Academy of Sciences, 2013
- Hepatocyte-specific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichmentCell Communication and Signaling, 2012
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell, 2012
- Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal NeutrophilsPLOS ONE, 2012
- miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during MetastasisCancer Cell, 2011
- Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growthOncogene, 2011
- Recent insights into the biological roles of mucin-type O-glycosylationGlycoconjugate Journal, 2008
- The Catalytic and Lectin Domains of UDP-GalNAc:Polypeptide α-N-Acetylgalactosaminyltransferase Function in Concert to Direct Glycosylation Site SelectionJournal of Biological Chemistry, 2008
- Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAILNature Medicine, 2007
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005